UK flag as shield

uk: Treat moderate to severely active ulcerative colitis

Treatment¬† recommendation: To treat moderate to severely active ulcerative colitis a final guidance was published recommending vedolizumab (Entyvio, Takeda) Vedolizumab provides a further treatment option when conventional therapy or TNF-alpha inhibitors either don’t work well, has stopped working or can’t be tolerated. Vedolizumab is recommended on basis it is provided to the NHS at a…

Read More